Ribociclib and Quetiapine: Interaction Details
- Quetiapine
- SeroquelSeroquel XR
- Ribociclib
- Kisqali
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Ribociclib and Quetiapine interaction:
Quetiapine
- Seroquel
- Seroquel XR
What Happens When You Take Ribociclib With Quetiapine
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Ribociclib should not be given together with drugs known to have the potential to prolong the , since the combination may further lengthen it. When such is unavoidable, monitoring is recommended at the start of the combination, throughout its duration, and whenever clinically needed.
If QTcF (QT interval corrected by the Fridericia formula) is above 480 ms and at or below 500 ms, management depends on the setting. In early breast cancer, ribociclib is interrupted until QTcF falls below 480 ms, and then restarted at the same dose.
In advanced or metastatic breast cancer, ribociclib is interrupted until QTcF falls below 480 ms, and then restarted at the next lower dose level. If QTcF above 480 ms occurs again, ribociclib is interrupted until QTcF returns to below 480 ms, and treatment resumes at the next lower dose level.
If QTcF exceeds 500 ms, ribociclib is interrupted until QTcF returns to below 480 ms, and then resumed at the next lower dose level. A repeat QTcF above 500 ms calls for discontinuing ribociclib.
Ribociclib must be permanently discontinued when QTcF prolongation is either above 500 ms or more than 60 ms above baseline and is accompanied by any of the following: torsade's de pointes, polymorphic ventricular , syncope, or signs or symptoms of serious . Ribociclib should also be discontinued if a dose reduction below 200 mg/day would be needed.1
The Ribociclib and Quetiapine Interaction, Explained
Both quetiapine (Seroquel, used for mood and thought conditions) and ribociclib (Kisqali, a breast cancer medicine) can affect the heart's electrical rhythm. Each can lengthen something called the , which is seen on an . Taking them together could add up this effect and raise the chance of a rare but serious irregular heartbeat. This concern is based mainly on how the drugs work rather than on direct studies of the pair.
Do not stop either medicine on your own. Your care team may check your heart tracing (ECG) and adjust your treatment if needed. Tell them right away if you feel faint, dizzy, or notice a racing or pounding heartbeat.
(). Both quetiapine and ribociclib are associated with dose-related QTc prolongation. Evidence is theoretical; severity on file is major; onset unspecified.
- Avoid where possible.
- If unavoidable, obtain at initiation, during concomitant use, and as clinically indicated. Correct electrolytes (K, Mg, Ca) as appropriate.
- QTcF >480 to 500 ms: interrupt ribociclib until QTcF 500 ms: interrupt until 500 ms or change from baseline >60 ms with torsades, polymorphic VT, syncope, or serious signs. Discontinue if reduction below 200 mg/day is required.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Ribociclib and Quetiapine Interact
The likely mechanism
How to Manage the Ribociclib and Quetiapine Interaction
Your care team will usually try to avoid combining these medicines. If you need both, they can manage the risk with monitoring and dose changes.
- You may have an when starting the combination, during treatment, and whenever needed.
- If your heart tracing shows a longer , your team may pause ribociclib and restart it at the same or a lower dose, depending on your situation. The dose may need to be adjusted and individualized by your care team.
- Keep taking both medicines as prescribed unless your team tells you otherwise.
- Tell your pharmacist or prescriber about all other medicines you take, and report fainting, dizziness, or palpitations right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Ribociclib or Quetiapine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Ribociclib and Quetiapine: Common Questions
How serious is the Ribociclib and Quetiapine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Ribociclib and Quetiapine interaction managed?
Your care team will usually try to avoid combining these medicines. If you need both, they can manage the risk with monitoring and dose changes. You may have an when starting the combination, during treatment, and whenever needed. If your heart tracing shows a longer , your team may pause ribociclib and restart it at the same or a lower dose, depending on your situation. The dose ma… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Ribociclib and Quetiapine Interaction
Ask in your own words about taking Ribociclib and Quetiapine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: KISQALI(R) oral tablets, ribociclib oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Ribociclib and Quetiapine
Also serious with Quetiapine
- Ketoconazole TopicalContraindicated
- LefamulinContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
Also serious with Ribociclib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Quetiapine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Indian SnakerootMajor
- + 195 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.